Immediate Impact
2 standout
Citing Papers
Drug Approval for the Treatment of Geographic Atrophy: How We Got Here and Where We Need to Go
2024 Standout
Immune-related adverse events of immune checkpoint inhibitors: a review
2023 Standout
Works of Charlotte Behning being referenced
Prevalence, therapy and tumour response in patients with rheumatic immune-related adverse events following immune checkpoint inhibitor therapy: a single-centre analysis
2021
FRI0548 PREVALENCE AND THERAPY OF RHEUMATOLOGICAL ADVERSE EVENTS DUE TO IMMUNE CHECKPOINT INHIBITOR THERAPY
2020
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Charlotte Behning | 56 | 39 | 47 | 44 | 43 | 164 | |
| Yukiko Takakuwa | 94 | 16 | 53 | 15 | 35 | 206 | |
| Thomas Sené | 86 | 69 | 74 | 15 | 31 | 253 | |
| Hakan Emmungil | 100 | 19 | 55 | 10 | 30 | 233 | |
| Chiharu Iwahashi | 33 | 166 | 30 | 58 | 31 | 240 | |
| Dong‐Ning Chen | 13 | 35 | 80 | 49 | 35 | 253 | |
| Eutília Andrade Medeiros Freire | 113 | 7 | 36 | 19 | 33 | 217 | |
| Mehmet Türe | 15 | 19 | 32 | 17 | 36 | 195 | |
| Naoto Azuma | 104 | 8 | 57 | 25 | 45 | 297 | |
| Rintaro Ohe | 19 | 9 | 32 | 22 | 40 | 237 | |
| Anca Bobîrcă | 40 | 10 | 17 | 11 | 49 | 155 |
All Works
Login with ORCID to disown or claim papers
Loading papers...